| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 23,205 | 24,879 | 24,076 | | Cost of Revenue | 7,354 | 9,801 | 9,759 | | | Gross Profit | 15,851 | 15,078 | 14,317 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 10,175 | 10,172 | 9,638 | | Non Recurring | 126 |
-
| 23 | | Others | 1,174 | 340 | 206 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 4,376 | 4,566 | 4,450 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| | Earnings Before Interest And Taxes | 4,376 | 4,566 | 4,450 | | Interest Expense | 1,967 | 1,992 | 1,439 | | Income Before Tax | 2,409 | 2,574 | 3,011 | | Income Tax Expense | 546 | 610 | 850 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,863 | 1,964 | 2,161 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 1,863 | 1,964 | 2,161 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,863 | $1,964 | $2,161 |
|
1.52% Nasdaq 0.00%
Income Statement
